Topic Highlight
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 21, 2013; 19(47): 8831-8849
Published online Dec 21, 2013. doi: 10.3748/wjg.v19.i47.8831
Table 3 Galectins in fibrosis-related liver pathologies
Galectin MemberExpressionFunction and/or effectModelRef.
Galectin-1Over-expressed in activated HSCsInduces proliferation of HSCs via ERK 1/2 through CRD domainHSCs activated in vitro (cultured on plastic for several days) and in vivo (isolated form rats treated with CCl4 or with bile duct ligation)[93,94]
Positive in ICC cells, intracellular expression and secretionCorrelates with histologic dedifferentiation, vascular invasion, and lymph node metastasisICC tissue samples, CCKS1 cholangiocarcinoma cell line[96]
Galectin-3Over-expressed in activated HSCsInduces proliferation via ERK 1/2 involving PKA and PKC pathwaysDependent on CRD domainHSCs activated in vitro (cultured on plastic for several days) and in vivo (isolated form rats treated with bile duct ligation)[94]
Intracellular Gal3 is required for activation of HSCs via TGF-βHSCs activated in vivo (isolated form rats treated with CCl4)[132]
Extracellular Gal3 required for activation of HSCs. Integrin and CRD dependent effectHSCs activated in vivo (isolated from rats with bile duct ligation)[134]
NFκβ induces expression and secretion of Gal3 in activated HSCs
Up-regulated in injured/cirrhotic hepatocytesPoor liver functionHuman fibrotic liver samples and extracts from rats treated with CCl4[124,133,136]
Related to the preneoplastic and early neoplastic stages of ICCICC tissue samples[96,137]
Positive in ICC cellsIntracellular expression is associated withanti-apoptotic activity and resistance to chemotherapeutic agentsICC cell lines[138]